Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020

BUY
$2.29 - $4.24 $57,250 - $106,000
25,000 New
25,000 $98,000
Q1 2020

May 15, 2020

SELL
$1.92 - $4.39 $52,621 - $120,316
-27,407 Closed
0 $0
Q4 2019

Jan 24, 2020

BUY
$2.41 - $4.4 $66,050 - $120,590
27,407 New
27,407 $102,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Advisor Partners LLC Portfolio

Follow Advisor Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.